Skip to content
ENYO Pharma logo

ENYO Pharma Alternatives & Competitors

12 companies similar to ENYO Pharma — Developing therapeutics for diseases with impaired kidney function

Companies similar to ENYO Pharma

GENFIT logo — alternative to ENYO Pharma

GENFIT

Dedicated to improving the lives of patients with liver diseases characterized by high unm...

ILIAS Biologics Inc. logo — alternative to ENYO Pharma

ILIAS Biologics Inc.

The Global Leader in Exosome-based Therapeutics

KAMADA logo — alternative to ENYO Pharma

KAMADA

Specialty Plasma-Derived Therapeutics

AusperBio logo — alternative to ENYO Pharma

AusperBio

Transforming Patient Lives For a Better Tomorrow

Rival Readout

Competing with ENYO Pharma? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
REGENXBIO logo — alternative to ENYO Pharma

REGENXBIO

Seeking to improve lives through the curative potential of gene therapy.

Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB) logo — alternative to ENYO Pharma

Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB)

A late stage clinical trial company focused on the development of novel therapeutics targe...

Biodexa Pharmaceuticals PLC logo — alternative to ENYO Pharma

Biodexa Pharmaceuticals PLC

Advancing Medicines for a Brighter Future

Emmaus Life Sciences, Inc logo — alternative to ENYO Pharma

Emmaus Life Sciences, Inc

Improving the lives of people with rare disease.

DevsHealth logo — alternative to ENYO Pharma

DevsHealth

At DevsHealth, we leverage our advanced DeepTech platform to enhance the development of an...

Perceive Biotherapeutics, Inc. logo — alternative to ENYO Pharma
MOGAM Institute for Biomedical Research logo — alternative to ENYO Pharma

MOGAM Institute for Biomedical Research

Advancing global health with AI-driven therapies for rare diseases, autoimmune disorders,...

Angitia Biopharmaceuticals logo — alternative to ENYO Pharma

Angitia Biopharmaceuticals

Developing innovative medicines to address serious musculoskeletal diseases

About ENYO Pharma

ENYO Pharma is a biopharmaceutical company that focuses on developing therapeutics for diseases with impaired kidney function. The company's lead compound, Vonafexor, is currently undergoing Phase 2 trials for Chronic Kidney Diseases (CKD), rare kidney diseases such as Alport syndrome, and liver diseases, including Non...

Services

Developing therapeutics for diseases with impaired kidney function

Target Customers

Patients with impaired kidney function, pharmaceutical companies, research institutions

Business keywords

Biopharmaceuticals, Therapeutics, Chronic Kidney Diseases, Rare Kidney Diseases, Liver Diseases, Infectious Diseases, Vonafexor, Intracellular Therapeutic Targets, Anti-virals, Drug Development, Phase 2 Trials, Research And Development, Inserm Patents, Viral Treatments, Global Leader

Frequently Asked Questions

Companies similar to ENYO Pharma include GENFIT, ILIAS Biologics Inc., KAMADA, AusperBio, REGENXBIO. They work in Biopharma and Biotechnology and share ENYO Pharma's focus on drug development, biopharmaceuticals and therapeutics.
Bounce Watch lists 12 companies that share ENYO Pharma's industries and are closest to it in business tags, services, target customers, business model and size.
ENYO Pharma is a biopharmaceutical company that focuses on developing therapeutics for diseases with impaired kidney function. The company's lead compound, Vonafexor, is currently undergoing Phase 2 trials for Chronic Kidney Diseases (CKD), rare kidney diseases such as Alport syndrome, and liver diseases, including Non...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around ENYO Pharma: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at ENYO Pharma on 11 Jun 2025. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout